Type 2 diabetes (T2D), cardiovascular disease and chronic kidney disease (CKD) often occur together in individuals due to shared risk factors. General practitioners play a central role in T2D management, identifying those at risk and providing optimal management.
Reducing Cardiovascular and Renal Risk in Type 2 Diabetes – More than just Glycaemic Control – ACRRM
AUS
$0
free
ACRRM
4.0 hrs
Endocrinology
4 Credits
Course Description
Course Details
Expiry Date: 2022-12-31
Professions: Physician
Faculty
Dr Gary Deed
MBBS, MRACGP
Professor Andrew Sindone
B. Med (Hons), MD, FRACP, FCSANZ, FNHFA
Dr Marwan Obaid
MBBS, BSc(Med), FRACP, MMed
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 3 hours of Educational Activity and 1 hour of Performance Review.
ACRRM activity ID: 25010
Learning Objective(s)
On completion of this program, participants will be able to:
- Describe the epidemiological and pathophysiological relationship between heart failure, chronic kidney disease and type-2 diabetes (T2D)
- Evaluate the risk or presence of cardiovascular and/or kidney disease when selecting treatment protocols for managing glycaemia in T2D and glucose-independent mechanisms of disease
- Implement appropriate management strategies for patients with T2D according to current national and international management guidelines
- Consider treatments for T2D which reduce CV and renal risk beyond glycaemic control
- Consider long-term patient wellbeing and safety regarding primary prevention of cardiovascular disease when selecting diabetes medicines